Hydrogen-Rich Water Improves Cognitive Ability and Induces Antioxidative, Antiapoptotic, and Anti-Inflammatory Effects in an Acute Ischemia-Reperfusion Injury Mouse Model.
Dain Lee, Jong-Il Choi · BioMed research international · 2021
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In C57BL/6 mice, western blotting showed that hydrogen treatment reduced Bax and TNFα levels. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in C57BL/6 mice. Western blotting showed that hydrogen treatment reduced Bax and TNFα levels.
What the Researchers Studied
The researchers studied C57BL/6 mice. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 1.2–2.0 mg/L H₂; Source-reported hydrogen exposure: 1.2–2.0 mg/L H₂; reported treatment duration: 5 weeks. Western blotting showed that hydrogen treatment reduced Bax and TNFα levels. The authors concluded that hydrogen treatment could potentially be a future therapeutic strategy for ischemia and its derived neurodegenerative diseases by improving cognitive abilities and inducing antioxidative and antiapoptotic effects. Total antioxidant capacity and thiobarbituric acid reactive substance assays revealed that hydrogen treatment induced antioxidative effects in the mouse brain.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was C57BL/6 mice. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 1.2–2.0 mg/L H₂. The source-reported hydrogen exposure was 1.2–2.0 mg/L H₂. The reported treatment duration was 5 weeks.
Limitations and Safety
Reported limitations: To make up for these limitations, a bigger number of protein candidates must be analyzed to assess its participation in the H₂ therapy mechanism in future studies.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.